Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 7 March 2008:
Vol. 319. no. 5868, pp. 1402 - 1405
DOI: 10.1126/science.1151363

Reports

Hepatic Glucose Sensing via the CREB Coactivator CRTC2

Renaud Dentin,1 Susan Hedrick,1 Jianxin Xie,2 John Yates, III,3 Marc Montminy1*

Chronic hyperglycemia contributes to the development of diabetes-associated complications. Increases in the concentration of circulating glucose activate the hexosamine biosynthetic pathway (HBP) and promote the O-glycosylation of proteins by O-glycosyl transferase (OGT). We show that OGT triggered hepatic gluconeogenesis through the O-glycosylation of the transducer of regulated cyclic adenosine monophosphate response element–binding protein (CREB) 2 (TORC2 or CRTC2). CRTC2 was O-glycosylated at sites that normally sequester CRTC2 in the cytoplasm through a phosphorylation-dependent mechanism. Decreasing amounts of O-glycosylated CRTC2 by expression of the deglycosylating enzyme O-GlcNAcase blocked effects of glucose on gluconeogenesis, demonstrating the importance of the HBP in the development of glucose intolerance.

1 The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
2 Cell Signaling Technology, 3 Trask Lane, Danvers, MA 01923, USA.
3 The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

* To whom correspondence should be addressed. E-mail: montminy{at}salk.edu

Read the Full Text



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes.
M. Saberi, D. Bjelica, S. Schenk, T. Imamura, G. Bandyopadhyay, P. Li, V. Jadhar, C. Vargeese, W. Wang, K. Bowman, et al. (2009)
Am J Physiol Endocrinol Metab 297, E1137-E1146
   Abstract »    Full Text »    PDF »
The Hexosamine Biosynthesis Pathway Is Essential for Pancreatic Beta Cell Development.
G. Filhoulaud, G. Guillemain, and R. Scharfmann (2009)
J. Biol. Chem. 284, 24583-24594
   Abstract »    Full Text »    PDF »
Regulation of Calcium/Calmodulin-dependent Kinase IV by O-GlcNAc Modification.
W. B. Dias, W. D. Cheung, Z. Wang, and G. W. Hart (2009)
J. Biol. Chem. 284, 21327-21337
   Abstract »    Full Text »    PDF »
Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein.
J. Chen, H. Cha-Molstad, A. Szabo, and A. Shalev (2009)
Am J Physiol Endocrinol Metab 296, E1133-E1139
   Abstract »    Full Text »    PDF »
Hexosamine Biosynthesis Pathway Flux Contributes to Insulin Resistance via Altering Membrane Phosphatidylinositol 4,5-Bisphosphate and Cortical Filamentous Actin.
P. Bhonagiri, G. R. Pattar, E. M. Horvath, K. M. Habegger, A. M. McCarthy, and J. S. Elmendorf (2009)
Endocrinology 150, 1636-1645
   Abstract »    Full Text »    PDF »
A PGC-1{alpha}-O-GlcNAc Transferase Complex Regulates FoxO Transcription Factor Activity in Response to Glucose.
M. P. Housley, N. D. Udeshi, J. T. Rodgers, J. Shabanowitz, P. Puigserver, D. F. Hunt, and G. W. Hart (2009)
J. Biol. Chem. 284, 5148-5157
   Abstract »    Full Text »    PDF »
The coactivator CRTC1 promotes cell proliferation and transformation via AP-1.
G. Canettieri, S. Coni, M. Della Guardia, V. Nocerino, L. Antonucci, L. Di Magno, R. Screaton, I. Screpanti, G. Giannini, and A. Gulino (2009)
PNAS 106, 1445-1450
   Abstract »    Full Text »    PDF »
Elevation of Global O-GlcNAc Levels in 3T3-L1 Adipocytes by Selective Inhibition of O-GlcNAcase Does Not Induce Insulin Resistance.
M. S. Macauley, A. K. Bubb, C. Martinez-Fleites, G. J. Davies, and D. J. Vocadlo (2008)
J. Biol. Chem. 283, 34687-34695
   Abstract »    Full Text »    PDF »
New Insights into Metabolic Signaling and Cell Survival: The Role of {beta}-O-Linkage of N-Acetylglucosamine.
G. A. Ngoh and S. P. Jones (2008)
J. Pharmacol. Exp. Ther. 327, 602-609
   Abstract »    Full Text »    PDF »
Activation of TORC1 Transcriptional Coactivator through MEKK1-induced Phosphorylation.
Y.-T. Siu, Y.-P. Ching, and D.-Y. Jin (2008)
Mol. Biol. Cell 19, 4750-4761
   Abstract »    Full Text »    PDF »
Regulation of Akt signaling by O-GlcNAc in euglycemia.
Y. A. Soesanto, B. Luo, D. Jones, R. Taylor, J. S. Gabrielsen, G. Parker, and D. A. McClain (2008)
Am J Physiol Endocrinol Metab 295, E974-E980
   Abstract »    Full Text »    PDF »
A Mitotic GlcNAcylation/Phosphorylation Signaling Complex Alters the Posttranslational State of the Cytoskeletal Protein Vimentin.
C. Slawson, T. Lakshmanan, S. Knapp, and G. W. Hart (2008)
Mol. Biol. Cell 19, 4130-4140
   Abstract »    Full Text »    PDF »
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
R. J. Copeland, J. W. Bullen, and G. W. Hart (2008)
Am J Physiol Endocrinol Metab 295, E17-E28
   Abstract »    Full Text »    PDF »
O-GlcNAc Regulates FoxO Activation in Response to Glucose.
M. P. Housley, J. T. Rodgers, N. D. Udeshi, T. J. Kelly, J. Shabanowitz, D. F. Hunt, P. Puigserver, and G. W. Hart (2008)
J. Biol. Chem. 283, 16283-16292
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)